Catalyst Pharmaceuticals Files 8-K
Ticker: CPRX · Form: 8-K · Filed: Aug 7, 2024 · CIK: 1369568
| Field | Detail |
|---|---|
| Company | Catalyst Pharmaceuticals, Inc. (CPRX) |
| Form Type | 8-K |
| Filed Date | Aug 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-update, financials
TL;DR
Catalyst Pharma filed an 8-K on Aug 7th. Standard update.
AI Summary
Catalyst Pharmaceuticals, Inc. filed an 8-K on August 7, 2024, reporting other events and financial statements/exhibits. The company, incorporated in Delaware, is based in Coral Gables, Florida, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates Catalyst Pharmaceuticals is providing updates and financial information to the SEC, which is standard for public companies but can signal upcoming events or disclosures.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain any immediately concerning information.
Key Numbers
- 001-33057 — SEC File Number (Identifies the company's filing with the SEC.)
- 76-0837053 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CATALYST PHARMACEUTICALS, INC. (company) — Registrant
- August 7, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Coral Gables, Florida (location) — Principal Executive Offices
- 355 Alhambra Circle, Suite 801 (address) — Business Address
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of filing 'Financial Statements and Exhibits' on an 8-K?
This indicates the company is providing updated financial information or exhibits as required by the SEC, which could include material contracts or other important documents.
When was Catalyst Pharmaceuticals, Inc. incorporated?
Catalyst Pharmaceuticals, Inc. was incorporated in Delaware.
What is the primary business address of Catalyst Pharmaceuticals, Inc.?
The primary business address is 355 Alhambra Circle, Suite 801, Coral Gables, Florida, 33134.
What is the SIC code for Catalyst Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 422 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2024-08-07 16:32:04
Key Financial Figures
- $0.001 — Ticker Symbol Common Stock, par value $0.001 per share NASDAQ Capital Market CPR
Filing Documents
- d873312d8k.htm (8-K) — 25KB
- d873312dex991.htm (EX-99.1) — 113KB
- 0001193125-24-195950.txt ( ) — 270KB
- cprx-20240807.xsd (EX-101.SCH) — 3KB
- cprx-20240807_lab.xml (EX-101.LAB) — 18KB
- cprx-20240807_pre.xml (EX-101.PRE) — 11KB
- d873312d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued by the Company on August 7, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Catalyst Pharmaceuticals, Inc. By: /s/ Michael Kalb Michael Kalb Executive Vice President and CFO Dated: August 7, 2024 3